LUKE TOLNAI: Open Payments
NPI 1285485342 · MOUNT CLEMENS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 80 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $348 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $356 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $274 |
| Alkermes, Inc. | 10 | $183 |
| Supernus Pharmaceuticals, Inc. | 7 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $131 |
| Indivior Inc. | 3 | $89 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Corium, LLC | 5 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Qelbree, SUBLOCADE, Auvelity, ABILIFY ASIMTUFII, Azstarys.
Industry payments across MI — which companies pay providers there.
